# Genetic and Epigenetic Risk of T2D in the UAE

> **NCT04270097** · — · UNKNOWN · sponsor: **Imperial College London Diabetes Centre** · enrollment: 1000 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04270097
- **Lead sponsor:** Imperial College London Diabetes Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03-23
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2020-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270097, "Genetic and Epigenetic Risk of T2D in the UAE". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04270097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*